---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-083356"
form_type: "8-K"
ticker: "VYNE"
cik: "0001566044"
company_name: "VYNE Therapeutics Inc."
filed_at: "2026-07-14T12:12:23+00:00"
generated_at: "2026-07-14T12:15:07.209875+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Yarrow Bioscience publishes investor presentation; VYNE makes available on website

## Summary
- Yarrow Bioscience published an investor presentation dated July 14, 2026, which VYNE made available on its website.
- The presentation is related to the proposed transaction between VYNE and Yarrow, as referenced in the S-4 registration statement.
- No specific financial or operational details from the presentation are included in the filing text provided.

## SEC filing metadata
- accession: 0001104659-26-083356
- form_type: 8-K
- ticker: VYNE
- cik: 0001566044
- company_name: VYNE Therapeutics Inc.
- filed_at: 2026-07-14T12:12:23+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1566044/000110465926083356/0001104659-26-083356-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1566044/000110465926083356/tm2620382d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-083356
- JSON: https://secwatch.observer/filing/0001104659-26-083356.json
- Plain text: https://secwatch.observer/filing/0001104659-26-083356.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.